
BioMed | An Open Access Journal from MDPI
Mar 12, 2021 · BioMed is an international, peer-reviewed, open access journal on the broad field of subjects in human life science and medicine published quarterly online by MDPI.
BMC Journals | Open access, community-focused - Springer
BMC is a leader in open access publishing, driving progress in the life sciences, health sciences, medicine and applied sciences.
Homepage - Biomed
IBSS BIOMED S.A. 80 years of experience in the production of vaccines and OTC drugs View products Meet the company Projects subsidized by EU funds About the company Leading producer of …
Home - BIOMED
BIOMED is a biotechnology healthcare platform utilizing cutting edge technology to develop and commercialize personalized and precision medicine to improve healthcare outcomes for patients.
Biomed - Biomed
Biomed’s purpose since 1995 is to provide quality proven remedies, protocols, and education to health professionals to help improve their patient’s quality of life.
BioMed Research International - Wiley Online Library
BioMed Research International is an open access journal publishing original research articles, review articles, and clinical studies covering a wide range of subjects within the biomedical sciences.
About us - Biomed
The Institute of Biotechnology of Sera and Vaccines BIOMED S.A. is a Polish biotechnology company with roots dating back to 1949. Throughout this time, we have been accumulating experience and …
BioMed | Aims & Scope - MDPI
BioMed (ISSN 2673-8430) is an international, peer-reviewed, open access journal that aims to provide a publishing platform covering the broad field of subjects in human life science and medicine.
BioMed Realty
Purpose-built lab and office environments across US and UK. BioMed Realty enables breakthrough science and technology through resilient infrastructure and tenant-first service.
Biomed Industries, Inc.™
Through the integration of high-content data using artificial intelligence, Biomed delves deeply into the mechanisms of action of diverse drug therapeutics. This approach enables us to swiftly pinpoint safe …